FundraiseBase by

EvlaBio

Raised $24.6M in a Seed round, announced 7 July 2025.

Total raised: $24.6M

Latest round SeedCountry SwitzerlandSector Health

Round

$24.6MSeed, 7 July 2025

Funds preclinical development toward IND-enabling studies.

Amount: $24.6M
Stage: Seed
Announced: 7 July 2025
Lead: Kurma Partners
Other investors: AdBio Partners, Boehringer Ingelheim Venture Fund, NRW.Venture, HTGF
Use of funds: Funds preclinical development toward IND-enabling studies.
Checked: Announced by the company
Sources: EvlaBio secures €21 million in seed funding - Startupticker.ch htgf.de
EvlaBio secures €21 million in seed funding startupticker.ch

Company

Biotech developing an antibody for left ventricular hypertrophy in chronic kidney disease.

Based in: Zurich, Switzerland
Sector: Health
Website: evlabio.com ↗

Links

Website: evlabio.com ↗

Questions

How much has EvlaBio raised?

EvlaBio raised $24.6M in a Seed round, announced on 7 July 2025.

Who invested in EvlaBio?

Kurma Partners led. Investors include Kurma Partners, AdBio Partners, Boehringer Ingelheim Venture Fund, NRW.Venture and HTGF.